# Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma

> **NCT03784781** · — · WITHDRAWN · sponsor: **Assistance Publique - Hôpitaux de Paris**

## Conditions studied

- Severe Asthma

## Interventions

- **BIOLOGICAL:** Biopsy
- **BIOLOGICAL:** Blood collection
- **BIOLOGICAL:** Bronchoalveolar lavage

## Key facts

- **NCT ID:** NCT03784781
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-06-09
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study never started
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03784781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03784781, "Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03784781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*